CHIP-JAK2V617F, chronic inflammation, abnormal megakaryocyte morphology, organ failure, and multimorbidties

被引：5
|
作者：
Hasselbalch, Hans Carl [1 ,2 ,6 ]
Kristiansen, Marie Hvelplund [1 ,3 ]
Kjaer, Lasse [2 ]
Skov, Vibe [2 ]
Larsen, Morten Kranker [1 ,2 ]
Ellervik, Christina [1 ,4 ,5 ]
Wienecke, Troels [1 ,3 ]
机构：
[1] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[2] Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark
[3] Zealand Univ Hosp, Dept Neurol, Roskilde, Denmark
[4] Dept Data & Data Support, Reg Zealand, Soro, Denmark
[5] Harvard Med Sch, Childrens Hosp Boston, Dept Lab Med, Boston, MA USA
[6] Zealand Univ Hosp, Dept Hematol, Vestermarksvej 5-7, DK-4000 Roskilde, Denmark
来源：
BLOOD ADVANCES | 2024年 / 8卷 / 03期
关键词：
ISCHEMIC-STROKE; JAK2V617F;
D O I：
10.1182/bloodadvances.2023012190
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：681 / 682
页数：2
相关论文
共 50 条
  • [31] JAK2 p.V617F Mutations Are Common in Chronic Myelomonocytic Leukemia with Fibrosis
    Gur, Deniz
    Loghavi, Sanam
    Routbort, Mark J.
    Garcia-Manero, Guillermo
    Yin, Cameron
    Li, Shaoying
    Medeiros, L. Jeffrey
    Khoury, Joseph D.
    LABORATORY INVESTIGATION, 2017, 97 : 353A - 353A
  • [32] The JAK2 V617F mutation in Philadelphia-negative chronic myeloproliferative disorders
    Stoj, Anastazja
    Rudzki, Zbigniew
    Stachura, Jerzy
    Sacha, Tomasz
    Czekalska, Sylwia
    JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (09) : 1070 - 1071
  • [33] JAK2 p.V617F Mutations Are Common in Chronic Myelomonocytic Leukemia with Fibrosis
    Gur, Deniz
    Loghavi, Sanam
    Routbort, Mark J.
    Garcia-Manero, Guillermo
    Yin, Cameron
    Li, Shaoying
    Medeiros, L. Jeffrey
    Khoury, Joseph D.
    MODERN PATHOLOGY, 2017, 30 : 353A - 353A
  • [34] A study of JAK2 (V617F) gene mutation in patients with chronic myeloproliferative disorders
    Hamidah, N. H.
    Farisah, N. R.
    Azlinda, A. B.
    Wong, F. L.
    Das, S.
    Fadillah, S. A. W.
    Ainoon, O.
    CLINICA TERAPEUTICA, 2012, 163 (02): : 109 - 113
  • [35] Chronic myeloproliferative diseases with concurrent BCR–ABL junction and JAK2V617F mutation
    K Hussein
    O Bock
    K Theophile
    A Seegers
    H Arps
    O Basten
    K-H Grips
    J Franz-Werner
    G Büsche
    H Kreipe
    Leukemia, 2008, 22 : 1059 - 1062
  • [36] JAK2-V617F Mutation and BCR-ABL Rearrangement in Chronic Myeloproliferative Neoplasms
    Zahra, M. K.
    El-Fadaly, N. H.
    Aboul-Enein, K. M.
    Elgamal, B. M.
    Abd El-Naby, Amira Y.
    Amer, Eman A.
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2012, 9 (02): : 403 - 414
  • [37] Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutation
    Mc Lornan, Donald P.
    Percy, Melanie J.
    Jones, Amy V.
    Cross, Nicholas C. P.
    Mc Mullin, Mary Frances
    HAEMATOLOGICA, 2005, 90 (12) : 1696 - +
  • [38] Prevalence of JAK2 V617F mutation in Indian patients with chronic myeloproliferative disorders
    Sazawal, Sudha
    Bajaj, Jyoti
    Chikkara, Sunita
    Jain, Sonal
    Bhargava, Rahul
    Mahapatra, Manoranjan
    Saxena, Renu
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2010, 132 (04) : 423 - 427
  • [39] JAK2V617F Mutation in Chronic Myeloid Leukemia Predicts Early Disease Progression
    Pahore, Zaen-Al-Abideen
    Shamsi, Tahir S.
    Taj, Mehwesh
    Farzana, Tasneem
    Ansari, Saqib H.
    Nadeem, Muhammad
    Ahmad, Masood
    Naz, Arshi
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2011, 21 (08): : 472 - 475
  • [40] JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia
    Pich, A.
    Riera, L.
    Sismondi, F.
    Godio, L.
    Bonino, L. Davico
    Marmont, F.
    di Celle, P. Francia
    JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (09) : 798 - 801
12345